Emergent BioSolutions Inc.

EBS·NYSE·Healthcare
Compare
5.90−0.35 (−5.60%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close6.25
Open6.43
Day range5.786.47
52-week range4.3614.06
Off day high−8.74%
Off 52-week high−58.04%
Volume2.18M
Avg. volume (3M)1.31M
Market cap303.35M
EPS (TTM)-5.00
Forward P/E5.64
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.37
Shares outstanding51.42M
Short interest19.19% of float
Earnings dateNov 2, 2026
Analyst target11.00
Profit margin−40.16%

Against its peers

Compare in full ›
EBS CJH.F AMPH HESTERBIO.BO 300601.SZ MEGA.BK
Market cap 303.35M 755.95M 1.19B 20.58B 14.41B 30.95B
P/E (TTM) — 153.0 16.6 15.0 117.3 14.2
Forward P/E 5.6 — 8.8 45.4 45.0 12.4
Price/book 1.0 1.1 1.6 5.7 1.5 3.0
Dividend yield — — — 0.47% 0.49% 4.86%
1-year change −42.55% −41.70% +15.64% +45.65% −25.16% +20.69%
Today −5.60% +6.25% +3.32% +4.34% +1.57% +1.43%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All EBS news ›
The Motley Fool··3 outlets

Emergent BioSolutions (EBS) Q3 2026 Earnings Call Transcript

Revenue fell 52% on delivery timing, but debt dropped 55% and guidance rose on margins. Operator: Hello, everyone. Thank you for joining us, and welcome to the Emergent BioSolutions Third Quarter 2026 Earnings Call. [Operator Instructions]…

More from 2 other outlets
WTOP News·Negative

Emergent Biosolutions: Q3 Earnings Snapshot

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Monday reported a loss of $32.7 million in its third quarter. On a per-sha On a per-share basis, the Gaithersburg, Maryland-based company said it had a…

Investor's Business Daily·Positive

Emergent Biosolutions Sees IBD RS Rating Rise To 73

A Relative Strength Rating upgrade for Emergent Biosolutions shows improving technical performance. Will it continue? Emergent Biosolutions (EBS) saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an increase…

The Globe and Mail·Negative

Emergent BioSolutions Announces CFO Transition Amid Transformation

Emergent Biosolutions ( (EBS) ) has shared an update. Emergent BioSolutions announced on October 16, 2026, that longtime chief financial officer Richard S. Lindahl will retire from his role on December 31, 2026, after nearly nine years at…

EBS

From the 4Search news index, newest first.

In the news

24mentions in 30 days
23with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 24 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance